Details of the Drug Reposition

General Information of This Drug (ID: DMIW227)

Drug Name	INO-3112 DMIW227

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Cervical cancer	DISFSHPF	2C77.0	Phase 1/2	[1]
Head and neck cancer	DISBPSQZ	2D42	Phase 1/2	[2]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT02172911) A Study of VGX-3100 and INO-9012 DNA Vaccine With Electroporation in Patients With Cervical Cancer. U.S. National Institutes of Health.